L. Hauser
14 Papers
44 Citations
L. Hauser is an academic researcher. The author has contributed to research in topics: Hepatitis E & Blood transfusion. The author has an hindex of 6, co-authored 13 publications.
Chat about Author
Papers
Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.
L. Hauser,Anne-Marie Roque-Afonso,A. Beyloune,M. Simonet,Bénédicte Deau Fischer,Nicolas Burin des Roziers,Vincent Mallet,Pierre Tiberghien,Philippe Bierling +8 more
TL;DR: Hepatitis E virus (HEV) is a small nonenveloped RNA virus usually transmitted by the enteric route, although transmission by blood transfusion has also been reported.
131
Complications pulmonaires de la transfusion (TACO–TRALI)
P. Renaudier,Danielle Rebibo,C. Waller,S. Schlanger,M.-P. Vo Mai,N. Ounnoughene,P. Breton,Stéphane Cheze,A. Girard,L. Hauser,J.-F. Legras,A. Saillol,Béatrice Willaert,C. Caldani +13 more
TL;DR: Les œdemes pulmonaires survenant pendant ou apres une transfusion figurent parmi les accidents graves les plus frequents, dans le systeme francais d'hemovigilance.
27
Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study.
Vincent Mallet,Vincent Mallet,Rebecca Sberro-Soussan,Anne-Marie Roque-Afonso,Anaïs Vallet-Pichard,Anaïs Vallet-Pichard,Bénédicte Deau,Alix Portal,Alix Portal,Marie-Laure Chaix,L. Hauser,A. Beyloune,Anne Mercadier,Jacques Izopet,Jacques Izopet,Christophe Legendre,Stanislas Pol,Stanislas Pol +17 more
TL;DR: Plasma exchange, including with pathogen-reduced plasma, is a risk factor for posttransplantation HEV infection and transaminase elevation and Screening for HEV RNA should be carried out in kidney transplant recipients treated with plasma exchange.
15
L’introduction de solutions de conservation dans les concentrés plaquettaires : vers une diminution des réactions transfusionnelles
D. Rebibo,M. Simonet,L. Hauser +2 more
TL;DR: In this paper, a porte sur trois years of transfusion in France is presented, where les concentres plaquettaires (CP) sont utilises dans les thrombopenies en traitement curatif ou preventif face au risque hemorragique des patients.
13
Fatal transfusion-transmitted infection due to Citrobacter koseri
L. Hauser,Senbetta Menasie,Stéphane Bonacorsi,Laurence Raoult,Nourredine AitOubelli,Marie Belloy,David Avran,A. Beyloune,M. Simonet,Typhaine Billard-Pomares,Béatrice Pangon,Philippe Bierling +11 more
TL;DR: Transfusion‐transmitted bacterial infection (TTBI) is still one of the most feared complications of blood transfusion.
9